Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Cannabist Company Holdings Inc N.CBST

Alternate Symbol(s):  CBSTF | N.CCHW | N.CCHW.WT

The Cannabist Company Holdings Inc. is a cultivator, manufacturer and provider of cannabis products and related services, with licenses in 15 United States jurisdictions. The Company’s principal business activity is the production and sale of cannabis as regulated by the regulatory bodies and authorities of the jurisdictions in which it operates. The Company operates approximately 124 facilities, including 93 dispensaries and 31 cultivation and manufacturing facilities, including those under development. The Company is a multi-state provider of cannabis in the United States and delivers products and services to both the medical and adult-use markets. Its retail brand, Cannabist, creates a national dispensary network that leverages proprietary technology platforms. The Company offers products spanning flower, edibles, oils and tablets, and manufactures brands including Seed & Strain, Triple Seven, Hedy, gLeaf, Classix, Press, and Amber.


NEO:CBST - Post by User

Post by Betteryear2on Nov 01, 2021 4:52pm
331 Views
Post# 34074833

Completes Acquisition of Colorado-Based Medicine Man

Completes Acquisition of Colorado-Based Medicine Man

 

Adds Four Denver-Metro Retail Locations and a 35,000-Square-Foot Indoor Cultivation Facility

Immediately Accretive to Columbia Care’s Adjusted EBITDA and Cash Flow from Operations

Solidifies Columbia Care’s Position as the Leading Retailer, Cultivator and Manufacturer in Colorado

Columbia Care Inc. (NEO: CCHW) (CSE: CCHW) (OTCQX: CCHWF) (FSE: 3LP) (“Columbia Care” or the “Company”), one of the largest and most experienced cultivators, manufacturers and distributors of cannabis products in the United States, today announced it has completed its acquisition of Medicine Man, a premier, vertically integrated Colorado-based cannabis company that has been serving the Denver metro area since 2009.

Total upfront consideration was $42.0 million, comprised of $8.4 million in cash and $33.6 million in stock, with the potential for an additional milestone payment based on 2021 performance. The transaction is immediately accretive to Adjusted EBITDA and cash flow from operations. Upfront consideration of $42.0 million represents a multiple of approximately 4.5x projected 2021 EBITDA.

“As the second largest cannabis market in the world, Colorado has become a global bellwether for adult use programs and continues to show strong organic growth. The acquisition of Medicine Man enhances our position as the leader in the state by combining with a recognized operator that has been a consistent outperformer in the Colorado market since its founding,” said Nicholas Vita, CEO of Columbia Care. “We are grateful to the cities of Aurora, Denver and Thornton, and the State of Colorado, for their support, as well as to the Medicine Man team that has been terrific to work with throughout this process. Our vision and values are aligned, and we look forward to expanding our Columbia Care family with the addition of those who made Medicine Man such a successful company.”

This acquisition adds one cultivation facility and four dispensaries to Columbia Care’s Colorado operations, including the Medicine Man Longmont location, which is anticipated to close in Q1 2022. Columbia Care’s footprint in Colorado will now total 26 dispensaries and six cultivation and manufacturing facilities, including those under The Green Solution brand.

“This marks the next step in the evolution of Medicine Man, from an ambitious family-run company to part of a best-in-class operation. Our experience with Columbia Care through this process has reinforced the reasons we decided to partner with them. The team has been incredible, fair and efficient over the last few months. Our focus now turns to executing their vision and bringing as much value as possible to the Columbia Care operation,” said Sally Vander Veer, CEO of Medicine Man.

For additional information regarding the transaction, please refer to Columbia Care’s press release issued on June 15, 2021, or visit the presentations section of the investors’ website.

<< Previous
Bullboard Posts
Next >>